BIOCON

Biocon Ltd.

Latest scanner signal, chart levels and stage timeline for BIOCON. Research only, not advice.

Latest status
Pre-Breakout
Weak
Scan date 2026-05-11
₹392.1
Latest price
7.0
Latest scanner score
10
Saved appearances
large_mid
Healthcare

AI Insights

Generated with AI

These insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.

Sign in to unlock AI Insights

Personalised swing trade analysis powered by Gemini AI

Sign In to View

Results & Fundamentals Lens

Constructive trend

Latest quarterly snapshot saved for BIOCON. Use it with price action, not as standalone advice.

Acceleration Moderate Quarter ended 2025-12-31
Revenue YoY
Top-line growth vs same quarter last year
+9.2%
Revenue QoQ
Sequential sales momentum
-2.1%
EPS YoY
Profit growth vs same quarter last year
+409.5%
EPS QoQ
Sequential earnings momentum
+64.6%
Event Radar
2026-08-06
87 days until next reported result date.
Fundamentals fetched2026-05-08
Calendar fetched2026-05-11
What to notice
Fundamentals are supportive: growth is respectable enough to back follow-through on valid setups.
Sequential revenue eased but EPS improved — check seasonality and operating leverage in the notes.
YoY and QoQ deltas benchmark the latest reported quarter ending 2025-12-31.

Detailed Scanner Breakdown

Detailed fields from the latest pre-breakout row.

Weak · 7.0
Price ₹392.1
Stage Unknown
RS trend
Sector RS 0.0%
Base
Base quality
Vol quality
Failure risk
RS rank
RSI 74.7
ADX 23.2
Avg value
Distribution 0 day(s)
VCP
Vol dry No
Flags None
Scanner Notes
✓ SKIP: 50DMA below 150DMA (371.02 <= 376.28)